# The Effect of Superoxide Dismutase on Inhibition of Acute Kidney Injury Induced by Sepsis Based on Kidney Tissue Histology and Murine Sepsis Score

Authors: Jufitriani Ismy; Maimun Syukri; Dessy R. Emril; Nanan Sekarwana; Jufriady Ismy; Rachmad Suhanda
Journal: The Scientific World Journal
 (2021)

---

## Abstract

Sepsis is one of the leading causes contributing to the incidence of acute kidney injury (AKI). Oxidative stress can be used as the main approach against sepsis-induced AKI. One of the primary antioxidants that plays a role in warding off oxidative stress is superoxide dismutase (SOD). This research aimed to observe the effect of antioxidant SOD in inhibiting sepsis in AKI based on kidney tissue histopathology. The research method was an experimental laboratory with a post-test-only control group design. Twenty-five adult male rats aged 12–16 weeks, weighing between 200 and 250 g, were randomly divided into five groups: Group I, as a positive control, where rats were injected with lipopolysaccharides (LPS); Group II, as a negative control; Group III, as treatment 1, where rats were injected with LPS and administered orally with SOD (Glisodin®) 250 IU daily; Group IV, as treatment 2, where rats were injected with LPS and administered orally with SOD (Glisodin®) 500 IU daily; and Group V, as treatment 2, where rats were injected with LPS and administered orally with SOD (Glisodin®) 1000 IU daily. Rats were administered with SOD (Glisodin®) by oral gavage with a flexible feeding tube for 16 weeks, given once daily in the morning, and then injected with LPS of 10 mg/kg body weight. Glisodin SOD had a significant effect on murine sepsis score (MSS). MSS influenced the tubular injury score linearly. We conclude that the optimal dose of SOD at 1000 IU for inhibiting sepsis-induced AKI incidence is compared to SOD at a dose of 250 and 500 IU. The antioxidant effect of SOD can prevent sepsis-induced AKI with oxidative stress events.


---

## Body

## 1. Introduction

Sepsis is a fundamental problem in health care with a high mortality rate. The incidence of sepsis is reported to increase with increasing life expectancy associated with comorbid factors [1]. Sepsis does not always show the same symptoms in every patient. Based on sepsis characteristics, several parameters assess the sepsis disorder experienced by sepsis sufferers. A murine sepsis score (MSS) assessment is based on seven criteria: appearance, level of awareness, activity, response to stimuli, eyes, respiratory rate, and breathing quality [2].Sepsis is one of the leading causes contributing to the incidence of acute kidney injury (AKI). Data on adults and children nationally in the United States showed that sepsis accounted for 26%–50% of AKI as a cause of AKI compared to 7%–10% of AKI due to primary kidney disease [3]. The high incidence of child AKI cases, namely, between 5% of inpatients and 30%–50% in intensive care units, proves that AKI is at a high alert level [4].Several factors play a role in sepsis-induced AKI, including ischemic-reperfusion injury to the glomerulus, inflammation of the nephrons, hypoxia and oxidative stress, cytokines, and chemokines that cause tubular injury and apoptosis in mesenchymal cells [5–7]. Oxidative stress is considered as the main mechanism against sepsis-induced AKI [8].Oxidative stress is a condition where there is an imbalance between oxidants and antioxidants in the body. One of the primary antioxidants responsible for counteracting oxidative stress is superoxide dismutase (SOD). Constantino et al. [9] stated that SOD is one of the natural antioxidant enzymes found in body cells due to several factors. As you grow older, this antioxidant activity can decrease so that antioxidants from outside the body are needed, one of which is Glisodin, a synthetic SOD. This study showed that the presence of SOD reduced levels of nitrotyrosine and proinflammatory cytokines that play a role in sepsis (p<0.05).Based on the above explanation, this study intended to determine the effect of the antioxidant SOD in inhibiting sepsis in AKI based on kidney tissue histopathology.


## 2. Materials and Methods

### 2.1. Reagents

Lipopolysaccharides (LPS,Escherichia coli O55 : B5) were purchased from Sigma-Aldrich (St. Louis, MO, USA). SOD extract was obtained as gliadin combined with standardized melon SOD (Glisodin®).


### 2.2. Animals and Treatments

Twenty-five adult maleRattus norvegicus rats (12–16 weeks), weighing 200–250 g, were obtained from the Experimental Animal Centre of Gadjah Mada University (Yogyakarta, Indonesia). The rats were acclimated for 1 week in the laboratory of Veterinary Medicine at Syiah Kuala University (Banda Aceh, Indonesia). The rats were allowed free access to water and food. Ethical clearance approval for using animals was obtained from the Veterinary Ethics Committee, Faculty of Veterinary Medicine, Syiah Kuala University (No. 20/KEPH/II/2019).Rats were randomly divided into five groups: Group I, as a positive control, rats were injected with LPS; Group II, as a negative control; Group III, as treatment 1, rats were injected with LPS and administered orally with SOD (Glisodin®) 250 IU daily; Group IV, as treatment 2, rats were injected with LPS and administered orally with SOD (Glisodin®) 500 IU daily; and Group V, as treatment 3, rats were injected with LPS and administered orally with SOD (Glisodin®) 1000 IU daily. SOD was given for 16 weeks by oral gavage with a flexible feeding tube, given once daily in the morning, and then rats were intraperitoneally injected with LPS at a dose of 10 mg/kg body weight. Control group (Groups I and II) rats were given an equal volume of saline for 16 weeks by oral gavage and then were intraperitoneally injected with saline.All rats were sacrificed after 12 h of injection of LPS, and the kidney tissue was collected, fixed in 10% formalin, and then embedded in paraffin to collect the kidney. Anesthesia with ketamine and xylazine and cervical dislocation were performed as the sacrifice methods.


### 2.3. Histopathological Analysis of the Kidney

After 12 h of injection of LPS, the kidney tissues were collected, fixed in 10% formalin, and embedded in paraffin. After dehydrating with graded alcohols for staining and sectioning into 5-µm sections, the sections were stained with hematoxylin and eosin. All sections were observed under a light microscope.Tubular injury scores are classified into four ranging from 0 to 3, as follows:(i)
Score 0: normal histological picture(ii)
Score 1: edema of tubular cells, loss of brush border, nuclear condensation, <1/3 of the tubular nucleus profile is missing(iii)
Score 2: as with score 1, 1/3–2/3 of the tubular nucleus profile is missing(iv)
Score 3: >2/3 of the tubular nucleus profile is missing


### 2.4. Murine Sepsis Score

The MSS system involves observing seven components, namely, appearance, level of awareness, activity, response to stimuli, eyes, respiratory rate, and breathing quality. The MSSs assigned were the average of these seven components [10]. Table 1 shows a detailed score and description of each variable in the MSS.Table 1
Murine sepsis score.
Murine sepsis scoreVariablesScore and description01234AppearanceCoat is smoothPatches of hair piloerectedMajority of the back is piloerectedPiloerection may or may not be present, and the mouse appears “puffy”Piloerection may or may not be present, and the mouse appears emaciatedLevel of consciousnessMouse is activeThe mouse is active but avoids standing uprightMouse activity is noticeably slowed. The mouse is still ambulantActivity is impaired. Mouse only moves when provoked, and movements have a tremorActivity is severely impaired. Mouse remains stationary when provoked, with possible tremorActivityA normal amount of activity. The mouse is doing all the eating, drinking, climbing, running, and fightingSlightly suppressed activity. The mouse is moving around the bottom of the cageSuppressed activity. The mouse is stationary with occasional investigative movementsNo activity. Mouse is stationaryNo activity. Mouse is experiencing tremors, particularly in the hind legsResponse to stimulusThe mouse responds immediately to auditory stimulus or touchSlow or no response to an auditory stimulus; strong response to touch (moves to escape)No response to an auditory stimulus; moderate response to touch (moves a few steps)No response to an auditory stimulus; mild response to touch (no locomotion)No response to an auditory stimulus. Little or no response to touch. It cannot right itself if pushed overEyesOpenEyes not fully open, possibly with secretionsEyes at least half-closed, possibly with secretionsEyes half-closed or more, possibly with secretionsEyes closed or milkyRespiration rateNormal, rapid mouse respirationSlightly decreased respiration (rate not quantifiable by eye)Moderately reduced respiration (the rate at the upper range of quantifying by eye)Severely reduced respiration (rate easily countable by eye, 0.5 s between breaths)Extremely reduced respiration (>1 s between breaths)Respiration qualityNormalBrief periods of labored breathingLabored, no gaspingLabored with intermittent gaspsGaspingSource: Shrum et al. (2014) [11].


## 2.1. Reagents

Lipopolysaccharides (LPS,Escherichia coli O55 : B5) were purchased from Sigma-Aldrich (St. Louis, MO, USA). SOD extract was obtained as gliadin combined with standardized melon SOD (Glisodin®).


## 2.2. Animals and Treatments

Twenty-five adult maleRattus norvegicus rats (12–16 weeks), weighing 200–250 g, were obtained from the Experimental Animal Centre of Gadjah Mada University (Yogyakarta, Indonesia). The rats were acclimated for 1 week in the laboratory of Veterinary Medicine at Syiah Kuala University (Banda Aceh, Indonesia). The rats were allowed free access to water and food. Ethical clearance approval for using animals was obtained from the Veterinary Ethics Committee, Faculty of Veterinary Medicine, Syiah Kuala University (No. 20/KEPH/II/2019).Rats were randomly divided into five groups: Group I, as a positive control, rats were injected with LPS; Group II, as a negative control; Group III, as treatment 1, rats were injected with LPS and administered orally with SOD (Glisodin®) 250 IU daily; Group IV, as treatment 2, rats were injected with LPS and administered orally with SOD (Glisodin®) 500 IU daily; and Group V, as treatment 3, rats were injected with LPS and administered orally with SOD (Glisodin®) 1000 IU daily. SOD was given for 16 weeks by oral gavage with a flexible feeding tube, given once daily in the morning, and then rats were intraperitoneally injected with LPS at a dose of 10 mg/kg body weight. Control group (Groups I and II) rats were given an equal volume of saline for 16 weeks by oral gavage and then were intraperitoneally injected with saline.All rats were sacrificed after 12 h of injection of LPS, and the kidney tissue was collected, fixed in 10% formalin, and then embedded in paraffin to collect the kidney. Anesthesia with ketamine and xylazine and cervical dislocation were performed as the sacrifice methods.


## 2.3. Histopathological Analysis of the Kidney

After 12 h of injection of LPS, the kidney tissues were collected, fixed in 10% formalin, and embedded in paraffin. After dehydrating with graded alcohols for staining and sectioning into 5-µm sections, the sections were stained with hematoxylin and eosin. All sections were observed under a light microscope.Tubular injury scores are classified into four ranging from 0 to 3, as follows:(i)
Score 0: normal histological picture(ii)
Score 1: edema of tubular cells, loss of brush border, nuclear condensation, <1/3 of the tubular nucleus profile is missing(iii)
Score 2: as with score 1, 1/3–2/3 of the tubular nucleus profile is missing(iv)
Score 3: >2/3 of the tubular nucleus profile is missing


## 2.4. Murine Sepsis Score

The MSS system involves observing seven components, namely, appearance, level of awareness, activity, response to stimuli, eyes, respiratory rate, and breathing quality. The MSSs assigned were the average of these seven components [10]. Table 1 shows a detailed score and description of each variable in the MSS.Table 1
Murine sepsis score.
Murine sepsis scoreVariablesScore and description01234AppearanceCoat is smoothPatches of hair piloerectedMajority of the back is piloerectedPiloerection may or may not be present, and the mouse appears “puffy”Piloerection may or may not be present, and the mouse appears emaciatedLevel of consciousnessMouse is activeThe mouse is active but avoids standing uprightMouse activity is noticeably slowed. The mouse is still ambulantActivity is impaired. Mouse only moves when provoked, and movements have a tremorActivity is severely impaired. Mouse remains stationary when provoked, with possible tremorActivityA normal amount of activity. The mouse is doing all the eating, drinking, climbing, running, and fightingSlightly suppressed activity. The mouse is moving around the bottom of the cageSuppressed activity. The mouse is stationary with occasional investigative movementsNo activity. Mouse is stationaryNo activity. Mouse is experiencing tremors, particularly in the hind legsResponse to stimulusThe mouse responds immediately to auditory stimulus or touchSlow or no response to an auditory stimulus; strong response to touch (moves to escape)No response to an auditory stimulus; moderate response to touch (moves a few steps)No response to an auditory stimulus; mild response to touch (no locomotion)No response to an auditory stimulus. Little or no response to touch. It cannot right itself if pushed overEyesOpenEyes not fully open, possibly with secretionsEyes at least half-closed, possibly with secretionsEyes half-closed or more, possibly with secretionsEyes closed or milkyRespiration rateNormal, rapid mouse respirationSlightly decreased respiration (rate not quantifiable by eye)Moderately reduced respiration (the rate at the upper range of quantifying by eye)Severely reduced respiration (rate easily countable by eye, 0.5 s between breaths)Extremely reduced respiration (>1 s between breaths)Respiration qualityNormalBrief periods of labored breathingLabored, no gaspingLabored with intermittent gaspsGaspingSource: Shrum et al. (2014) [11].


## 3. Results and Discussion

### 3.1. Results

The results showed that the animals’ weights were similar in each group (Table2), which indicated that there was no difference in rat body weight during the study period.Table 2
Descriptive data on experimental animal weight at the laboratory of the experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.WeightGroupNMean (g)SD (g)Min (g)Max (g)p∗p∗∗1StartI5231.0017.99216.00259.000.1950.121II5217.4018.26200.00246.000.354III5233.6022.10210.00267.000.698IV5241.8018.21216.00267.000.769V5248.8014.62227.00262.000.4512EndI5335.0032.02290.00370.000.5700.404II5374.2038.46325.00424.000.823III5322.4075.00257.00443.000.249IV5323.0044.22256.00360.000.302V5336.6022.61307.00368.000.996∗Data normality test with the Shapiro–Wilk test. ∗∗ANOVA test.MSS was used in this study to evaluate the severity of each group. Table3 shows that the MSSs increased significantly in the group that did not receive Glisodin®. These data suggest that Glisodin® decreases the severity of sepsis in rats.Table 3
Descriptive data of murine sepsis scores on experimental animals at the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.GroupnMeanSDMinMaxp∗p∗∗1I520.602.7018.0024.000.1660.0012II50000–3III522.403.2120.0028.000.0304IV516.203.4913.0020.000.0395V56.003.743.0012.000.235∗Data normality test with the Shapiro–Wilk test. ∗∗Kruskal–Wallis test.Only Group V has a symmetrical MSS distribution, as shown in Figure1. While the other groups were asymmetrical, with the majority of median values clustered in quartile 1 (Q1). In contrast, the MSS distribution diagram is a line in Group II because there is only one value.Figure 1
Murine sepsis score based on groups of experimental animals at the laboratory of the experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).The MSS was also examined in sepsis rats that received SOD Glisodin compared with healthy rats (Table4). The optimal doses of SOD Glisodin 1000 IU significantly decreased the MSS in sepsis rats. In addition, there was no significant difference in MSS in rats that received optimal doses of SOD Glisodin compared with healthy rats.Table 4
Comparison of murine sepsis scores of experimental animals in Group I compared to Groups III, IV, V, and II in the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.GroupGroupMean differenceSEp∗1IIII−1.801.880.9902IV4.401.970.4533V14.602.060.0024II20.601.210.001∗Post hoc Tamhane test.Furthermore, the highest tubular injury score was also obtained in this result (Table5). Although there were differences between groups, a significant difference test analysis of the tubular injury score (p<0.05) was obtained only between Group II and the other groups.Table 5
Descriptive data of tubular injury scores in experimental animals at the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.GroupnMeanSDMinMaxp∗p∗∗1I51.440.920.602.800.4370.0182II50.080.1100.200.0063III50.920.580.201.600.7424IV51.080.760.602.400.0195V50.920.230.601.200.814∗Data normality test with the Shapiro–Wilk test. ∗∗Kruskal–Wallis test.We also found that only Group IV shows a symmetrical distribution of the tubular injury score as shown in Figure2. In contrast with Groups I and IV, which shows asymmetrical distribution with the median values scattered in Q3. Additionally, the rest, namely, Groups II and III, are asymmetrical, but most of the median values are scattered in Q1.Figure 2
Tubular injury score based on groups of experimental animals in the laboratory of animal medicine, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).The histological features of the rat’s kidney tissue are shown in Figure3. Observations were made through an optical microscope with two magnification types, such as 10× and 40×. Meanwhile, the tubular injury score can be obtained in Table 5.Figure 3
Histology of rats’ kidney tissue based on the treatment group. (a) Group I at 10x magnification. (b) Group I at 40x magnification. (c) Group II at 10x magnification. (d) Group II at 40x magnification. (e) Group III at 10x magnification. (f) Group III at 40x magnification. (g) Group IV at 10x magnification. (h) Group IV at 40x magnification. (i) Group V at 10x magnification. (j) Group V at 40x magnification.
(a)(b)(c)(d)(e)(f)(g)(h)(i)(j)Administering SOD Glisodin has a significant effect on MSS. Table6 describes the contribution of SOD Glisodin to the change in MSS as 91.4%, or other factors influenced only 9.6%. The B value is obtained with the most considerable negative value in the group given SOD Glisodin of 1000 IU against the negative control group. This condition indicates that the higher dose of SOD Glisodin injection can affect the MSS value that is formed.Table 6
Results of the analysis of the effect of administering SOD Glisodin on murine sepsis scores based on the treatment group of experimental animals at the laboratory of animal medicine at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.Independent variableDependent variablep∗R2GroupBp∗∗1SOD GlisodinMurine sepsis score0.0010.914II−20.6000.001III1.8000.348IV−4.4000.029V−14.6000.001I0a–aThis parameter is set to zero because it is redundant. ∗Tests of between-subjects effects. ∗∗Parameter estimates.We can conclude that the injection of SOD Glisodin at doses of 500 and 1000 IU can be a protective factor against septic conditions in rats. The ideal dose given to rats that became experimental animals in this study is 1000 IU.Table7 also describes how the MSS affects the tubular injury score linearly. The higher the value of the independent variable, the higher the value of the dependent variable. The condition of sepsis in rats will affect the severity of tubular damage in the rats’ kidneys by 19.8%. We can conclude that the more severe sepsis occurs, the more severe the renal tubular damage will be.Table 7
Results of analysis of the effect of murine sepsis score on tubular injury score in experimental animals at the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.Independent variableDependent variableBpR21Murine sepsis scoreTubular injury score0.0340.0260.198


### 3.2. Discussion

Sepsis is a complex syndrome characterized by an imbalance between proinflammatory and anti-inflammatory responses to pathogens [9]. During the development of sepsis, a large number of reactive oxygen species (ROS) and nitric oxide (NO) will be produced [12]. ROS is very reactive, so it readily reacts with other compounds such as lipids, DNA, and proteins. Oxidation of ROS causes tissue or organ damage that can lead to disease [13]. Excess production of ROS and NO can cause oxidative stress due to the body’s antioxidants’ failure to ward off free radicals produced from ROS and NO. Antioxidants have free radical scavenging activities, which protect the body from various diseases caused by free radicals [14]. SOD is a natural antioxidant in the body that can prevent free radicals [15].SOD is a metalloenzyme that can catalyze the release of superoxide radicals into hydrogen peroxide and oxygen. Mammals have three distinct SOD isoforms, namely, copper/zinc-SOD (Cu/ZnSOD, SOD-1), manganese-SOD (MnSOD, SOD-2), and extracellular-SOD (ECSOD, SOD-3). These SOD isoforms act as catalysts to break down free radical molecules, namely, superoxide anions, into molecular oxygen and hydrogen peroxide [16]. Damage to the respiratory system and kidney tissue is the most common form of organ dysfunction in patients with sepsis [17]. Constantino et al. (2017) [9] explained that AKI is the main well-known complication of sepsis.One of the antioxidants that can decrease sepsis is SOD because it is the first defense enzyme found in body cells [13]. In the present study, the MSS and renal tubular damage in a rat model were used to evaluate the possible role of SOD in sepsis-induced AKI. Our results demonstrated that the SOD Glisodin treatment significantly decreased MSS and renal tubular damage.The role of SOD in the severe sepsis phase has been described in several studies that found the imbalance of SOD levels may increase the oxidative stress during sepsis, and it can induce severe sepsis and involve organ damage [14, 18]. Oxidative stress and myeloperoxidase (MPO)–a hemoprotein released into the extracellular fluid during the inflammatory process–may be involved in organ damage in sepsis through direct and indirect mechanisms by modulation of transcription factor activation [12, 19, 20]. Furthermore, increased levels of catalase are also associated with organ damage in sepsis [21, 22]. However, efforts to explain the proper cellular and molecular interactions in sepsis continue to yield exciting information.One of the organ damages that is feared in sepsis is AKI. The incidence of AKI in sepsis is approximately 16.2%, and the majority of these cases require renal replacement therapy [22]. The severity of AKI is highly correlated with the severity of sepsis [23], and adequate sepsis control will improve the prognosis of AKI [24]. Administration of SOD Glisodin may be an alternative therapy to control sepsis and reduces renal tubular damage, as we found in this animal model study. We believe the findings of this study can be the basis for developing the administration of SOD in cases of sepsis to prevent worsening of the prognosis. Further studies are still needed to validate these results.


## 3.1. Results

The results showed that the animals’ weights were similar in each group (Table2), which indicated that there was no difference in rat body weight during the study period.Table 2
Descriptive data on experimental animal weight at the laboratory of the experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.WeightGroupNMean (g)SD (g)Min (g)Max (g)p∗p∗∗1StartI5231.0017.99216.00259.000.1950.121II5217.4018.26200.00246.000.354III5233.6022.10210.00267.000.698IV5241.8018.21216.00267.000.769V5248.8014.62227.00262.000.4512EndI5335.0032.02290.00370.000.5700.404II5374.2038.46325.00424.000.823III5322.4075.00257.00443.000.249IV5323.0044.22256.00360.000.302V5336.6022.61307.00368.000.996∗Data normality test with the Shapiro–Wilk test. ∗∗ANOVA test.MSS was used in this study to evaluate the severity of each group. Table3 shows that the MSSs increased significantly in the group that did not receive Glisodin®. These data suggest that Glisodin® decreases the severity of sepsis in rats.Table 3
Descriptive data of murine sepsis scores on experimental animals at the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.GroupnMeanSDMinMaxp∗p∗∗1I520.602.7018.0024.000.1660.0012II50000–3III522.403.2120.0028.000.0304IV516.203.4913.0020.000.0395V56.003.743.0012.000.235∗Data normality test with the Shapiro–Wilk test. ∗∗Kruskal–Wallis test.Only Group V has a symmetrical MSS distribution, as shown in Figure1. While the other groups were asymmetrical, with the majority of median values clustered in quartile 1 (Q1). In contrast, the MSS distribution diagram is a line in Group II because there is only one value.Figure 1
Murine sepsis score based on groups of experimental animals at the laboratory of the experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).The MSS was also examined in sepsis rats that received SOD Glisodin compared with healthy rats (Table4). The optimal doses of SOD Glisodin 1000 IU significantly decreased the MSS in sepsis rats. In addition, there was no significant difference in MSS in rats that received optimal doses of SOD Glisodin compared with healthy rats.Table 4
Comparison of murine sepsis scores of experimental animals in Group I compared to Groups III, IV, V, and II in the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.GroupGroupMean differenceSEp∗1IIII−1.801.880.9902IV4.401.970.4533V14.602.060.0024II20.601.210.001∗Post hoc Tamhane test.Furthermore, the highest tubular injury score was also obtained in this result (Table5). Although there were differences between groups, a significant difference test analysis of the tubular injury score (p<0.05) was obtained only between Group II and the other groups.Table 5
Descriptive data of tubular injury scores in experimental animals at the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.GroupnMeanSDMinMaxp∗p∗∗1I51.440.920.602.800.4370.0182II50.080.1100.200.0063III50.920.580.201.600.7424IV51.080.760.602.400.0195V50.920.230.601.200.814∗Data normality test with the Shapiro–Wilk test. ∗∗Kruskal–Wallis test.We also found that only Group IV shows a symmetrical distribution of the tubular injury score as shown in Figure2. In contrast with Groups I and IV, which shows asymmetrical distribution with the median values scattered in Q3. Additionally, the rest, namely, Groups II and III, are asymmetrical, but most of the median values are scattered in Q1.Figure 2
Tubular injury score based on groups of experimental animals in the laboratory of animal medicine, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).The histological features of the rat’s kidney tissue are shown in Figure3. Observations were made through an optical microscope with two magnification types, such as 10× and 40×. Meanwhile, the tubular injury score can be obtained in Table 5.Figure 3
Histology of rats’ kidney tissue based on the treatment group. (a) Group I at 10x magnification. (b) Group I at 40x magnification. (c) Group II at 10x magnification. (d) Group II at 40x magnification. (e) Group III at 10x magnification. (f) Group III at 40x magnification. (g) Group IV at 10x magnification. (h) Group IV at 40x magnification. (i) Group V at 10x magnification. (j) Group V at 40x magnification.
(a)(b)(c)(d)(e)(f)(g)(h)(i)(j)Administering SOD Glisodin has a significant effect on MSS. Table6 describes the contribution of SOD Glisodin to the change in MSS as 91.4%, or other factors influenced only 9.6%. The B value is obtained with the most considerable negative value in the group given SOD Glisodin of 1000 IU against the negative control group. This condition indicates that the higher dose of SOD Glisodin injection can affect the MSS value that is formed.Table 6
Results of the analysis of the effect of administering SOD Glisodin on murine sepsis scores based on the treatment group of experimental animals at the laboratory of animal medicine at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.Independent variableDependent variablep∗R2GroupBp∗∗1SOD GlisodinMurine sepsis score0.0010.914II−20.6000.001III1.8000.348IV−4.4000.029V−14.6000.001I0a–aThis parameter is set to zero because it is redundant. ∗Tests of between-subjects effects. ∗∗Parameter estimates.We can conclude that the injection of SOD Glisodin at doses of 500 and 1000 IU can be a protective factor against septic conditions in rats. The ideal dose given to rats that became experimental animals in this study is 1000 IU.Table7 also describes how the MSS affects the tubular injury score linearly. The higher the value of the independent variable, the higher the value of the dependent variable. The condition of sepsis in rats will affect the severity of tubular damage in the rats’ kidneys by 19.8%. We can conclude that the more severe sepsis occurs, the more severe the renal tubular damage will be.Table 7
Results of analysis of the effect of murine sepsis score on tubular injury score in experimental animals at the laboratory of experimental animal at UPT, Faculty of Veterinary Medicine, Unsyiah, in 2020 (n = 25).
No.Independent variableDependent variableBpR21Murine sepsis scoreTubular injury score0.0340.0260.198


## 3.2. Discussion

Sepsis is a complex syndrome characterized by an imbalance between proinflammatory and anti-inflammatory responses to pathogens [9]. During the development of sepsis, a large number of reactive oxygen species (ROS) and nitric oxide (NO) will be produced [12]. ROS is very reactive, so it readily reacts with other compounds such as lipids, DNA, and proteins. Oxidation of ROS causes tissue or organ damage that can lead to disease [13]. Excess production of ROS and NO can cause oxidative stress due to the body’s antioxidants’ failure to ward off free radicals produced from ROS and NO. Antioxidants have free radical scavenging activities, which protect the body from various diseases caused by free radicals [14]. SOD is a natural antioxidant in the body that can prevent free radicals [15].SOD is a metalloenzyme that can catalyze the release of superoxide radicals into hydrogen peroxide and oxygen. Mammals have three distinct SOD isoforms, namely, copper/zinc-SOD (Cu/ZnSOD, SOD-1), manganese-SOD (MnSOD, SOD-2), and extracellular-SOD (ECSOD, SOD-3). These SOD isoforms act as catalysts to break down free radical molecules, namely, superoxide anions, into molecular oxygen and hydrogen peroxide [16]. Damage to the respiratory system and kidney tissue is the most common form of organ dysfunction in patients with sepsis [17]. Constantino et al. (2017) [9] explained that AKI is the main well-known complication of sepsis.One of the antioxidants that can decrease sepsis is SOD because it is the first defense enzyme found in body cells [13]. In the present study, the MSS and renal tubular damage in a rat model were used to evaluate the possible role of SOD in sepsis-induced AKI. Our results demonstrated that the SOD Glisodin treatment significantly decreased MSS and renal tubular damage.The role of SOD in the severe sepsis phase has been described in several studies that found the imbalance of SOD levels may increase the oxidative stress during sepsis, and it can induce severe sepsis and involve organ damage [14, 18]. Oxidative stress and myeloperoxidase (MPO)–a hemoprotein released into the extracellular fluid during the inflammatory process–may be involved in organ damage in sepsis through direct and indirect mechanisms by modulation of transcription factor activation [12, 19, 20]. Furthermore, increased levels of catalase are also associated with organ damage in sepsis [21, 22]. However, efforts to explain the proper cellular and molecular interactions in sepsis continue to yield exciting information.One of the organ damages that is feared in sepsis is AKI. The incidence of AKI in sepsis is approximately 16.2%, and the majority of these cases require renal replacement therapy [22]. The severity of AKI is highly correlated with the severity of sepsis [23], and adequate sepsis control will improve the prognosis of AKI [24]. Administration of SOD Glisodin may be an alternative therapy to control sepsis and reduces renal tubular damage, as we found in this animal model study. We believe the findings of this study can be the basis for developing the administration of SOD in cases of sepsis to prevent worsening of the prognosis. Further studies are still needed to validate these results.


## 4. Conclusions

MSS and tubular injury score were found to be decreased in the sample group added with the antioxidant SOD. These antioxidants play a role in suppressing oxidative stress that can cause AKI. SOD with a dose of 1000 IU was found to be very good at inhibiting the occurrence of AKI induced by sepsis compared to SOD with a dose of 250 and 500 IU. This shows that the antioxidant SOD can prevent the occurrence of AKI caused by sepsis by suppressing the occurrence of oxidative stress.



---

*Source: 1827296-2021-12-16.xml*